Biodexa Pharmaceuticals (BDRX)

NASDAQ: BDRX · Real-Time Price · USD

1.41

0.00 (0.00%)

At close: May 02, 2025, 11:12 AM

Biodexa Pharmaceuticals Balance Sheet Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.67M	5.97M	2.84M	10.06M	7.55M	10.93M	2.34M	13.2M	17.61M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-837K	-1.15M	-542K	2.63M	469K	465K	448K
Receivables	715K	704K	329K	33K	95K	22K	89K	2.23M	1.43M
Inventory	n/a	-704K	1.00	1.00	-1.38M	1.00	n/a	941K	817K
Other Current Assets	n/a	704K	n/a	n/a	n/a	2.64M	3.05M	1.58M	1.86M
Total Current Assets	8.81M	7.03M	4.69M	11.76M	9.28M	13.74M	5.62M	18.58M	22.3M
Property-Plant & Equipment	324K	571K	831K	1.15M	542K	2.15M	1.98M	2.53M	2.77M
Goodwill & Intangibles	5.65M	2.94M	6K	n/a	n/a	12.38M	12.37M	27.65M	31.17M
Total Long-Term Assets	5.97M	3.51M	837K	1.15M	542K	17.16M	14.83M	30.64M	34.39M
Total Assets	14.78M	10.54M	5.53M	12.91M	9.82M	30.89M	20.44M	49.22M	56.69M
Account Payables	707K	314K	339K	485K	337K	725K	286K	2.27M	3.27M
Deferred Revenue	1.47M	n/a	197K	n/a	68K	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	107K	179K	288K	322K	507K
Other Current Liabilities	921K	4.23M	583K	664K	1.68M	2.77M	792K	2.64M	3.54M
Total Current Liabilities	5.03M	5.57M	1.9M	1.84M	2.99M	5.67M	2.47M	8.36M	9.35M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	4.76M	714K	6.16M	1.57M
Other Long-Term Liabilities	1.31M	n/a	n/a	-469	50K	n/a	165K	n/a	n/a
Total Long-Term Liabilities	1.42M	295K	463K	619.53K	110K	5.67M	1.05M	6.18M	1.62M
Total Liabilities	6.46M	5.86M	2.36M	2.46M	3.1M	11.34M	3.52M	14.55M	10.96M
Total Debt	727K	464K	624K	766K	260K	6.08M	1.17M	6.51M	2.13M
Common Stock	6.69M	1.19M	1.11M	98.47K	63K	23K	3K	3K	2K
Retained Earnings	-150.42M	-144.77M	-135.34M	-127.8M	-122.43M	-99.84M	-89.72M	-74.65M	-59.11M
Comprehensive Income	53M	61.52M	53M	53M	53M	53.49M	53.7M	56.39M	57.62M
Shareholders Equity	8.32M	4.68M	3.16M	10.45M	6.72M	19.56M	16.92M	34.68M	45.72M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a